Summary
Signal counts
Assets tracked: 3
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Chang Gung Memorial Hospital
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT07248020 | https://clinicaltrials.gov/study/NCT03656042 | https://clinicaltrials.gov/study/NCT03898102 | https://clinicaltrials.gov/study/NCT02307500
Assets
Linked programs
- Curcumin (BCM-95®): Low Signal (0/5)
- Filgrastim (75mcg/0.3ml): Results Not Found Signal (2/5)
- Regorafenib: Results Not Found Signal (3/5)